Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jneuroim.2021.577627 http://scihub22266oqcxt.onion/10.1016/j.jneuroim.2021.577627 34139567!8183006!34139567     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34139567&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Neuroimmunol 2021 ; 357 (?): 577627 Nephropedia Template TP {{tp|p=34139567|t=2021. Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement |pdf=|usr=}}{{34139567}} gab.com Text Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement JO: J Neuroimmunol http://www.kidney.de/pget.php?&tw=1&pmid=34139567 #FOAvip In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues. Twit Text FOAVip Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement ????J Neuroimmunol http://www.kidney.de/pget.php?&tw=1&pmid=34139567 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34139567 #FOAvip English Wikipedia <ref>{{Cite pmid|34139567}}</ref> Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement #MMPMID34139567 Reyes S; Cunningham AL; Kalincik T; Havrdova EK; Isobe N; Pakpoor J; Airas L; Bunyan RF; van der Walt A; Oh J; Mathews J; Mateen FJ; Giovannoni G J Neuroimmunol 2021[Aug]; 357 (?): 577627 PMID34139567show ga In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues. |*Internationality[MESH] |COVID-19/*epidemiology/*therapy[MESH] |Disease Management[MESH] |Humans[MESH] |Multiple Sclerosis/*epidemiology/*therapy[MESH] |Pandemics/prevention & control[MESH] |Pharmacovigilance[MESH] |Practice Guidelines as Topic/*standards[MESH]Update on the management of multiple sclerosis during the COVID-19 pan(epmc).pdf DeepDyve Pubget Overpricing